Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

Executive Summary

Watson adds Actavis for $5.6 bil.; Recordati buys OTCs in Germany; DoJ weighs in on Plan B case; NARC rebranded as ASRC; Korean lawmakers miss another chance on OTC bill; more news In Brief.

Advertisement

Related Content

Actavis Realigns OTC, Rx Businesses To Increase Efficiency
Actavis’ Warner Chilcott Buy Brings Switch Options In Diversified Portfolio
Actavis’ Warner Chilcott Buy Brings Switch Options In Diversified Portfolio
Korea’s National Assembly Passes Long-Awaited OTC Drug Bill
Judge Likely To Order Lower Age Restriction For Emergency Contraceptives
Korean Lawmakers Focus On Elections, Pass On Expanding OTC Sales
In Brief

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105720

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel